Shares Of Chimerix Higher By Nearly 6% After Point72 Stake Reveal

December 31, 2015 8:24 AM | 27 seconds read | Make a Comment

Shares of

Chimerix IncCMRX

, a biopharmaceutical company that develops and commercializes oral antivirals, surged higher by nearly 6 percent early Thursday morning after Point72 Asset Management

disclosed a 5.3 percent stake in the company. Shares of Chimerix plunged more than 80 percent on Monday. Steve Cohen's Point72 Asset Management reported owning more than 2.45 million shares in the biotechnology company.

CNBC

noted that It is unclear if the purchase was made prior to or after Monday's plunge in Chimerix's stock.

Market News and Data brought to you by Benzinga APIs

Posted In: Biotech Long Ideas Hedge Funds Movers Trading Ideas General biotechnology Chimerix Point72 Asset Management

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!